Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chengda Suda rabies vaccine simplified 4-dose regimen phase III trial
CTR20211767Phase 3Completed
- Sponsor
- Liaoning Chengda Biotechnology Co., Ltd.
- Start
- Jul 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rabies vaccine (vero cell) in rabies, sponsored by Liaoning Chengda Biotechnology Co., Ltd.. Started Jul 2021; status: completed.
02
Drugs
rabies vaccine (vero cell)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20211767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211767.